Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Treatment Recommendations for Locally Advanced, Non-Small-Cell Lung Cancer: The Influence of Physician and Patient Factors
International Journal of Radiation Oncology*Biology*Physics, 08/10/09
Lee IH et al. – Nearly all radiation oncologists report following the evidence–based recommendation of chemoradiation for young, otherwise healthy patients with locally advanced, unresectable NSCLC, but there is substantial variability in treatment recommendations for older or sicker patients, probably related to the lack of clinical trial data for such patients. The physician and practice characteristics the authors examined only weakly affected treatment recommendations.
Today in Chest...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of Image Quality and Radiation Dose of Coronary Computed Tomographic Angiography Between Conventional Helical Scanning and a Strategy Incorporating Sequential Scanning
The American Journal of Cardiology, 11/06/09
Accuracy of preoperative ultrasound and ultrasound-guided fine needle aspiration cytology for axillary staging in breast cancer
Australian and New Zealand Journal of Surgery, 11/13/09
The Efficacy and Safety of Oral Pentobarbital Sedation in Pediatric Echocardiography
Journal of the American Society of Echocardiography, 11/03/09
Today in Radiotherapy (XRT)...keeping you current
Receive free subspecialty "5-minute updates" via email
Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2×2 randomised clinical trial in patients with low risk of recurrence
European Journal of Cancer, 11/05/09
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/11/09
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09
Sponsor
Article Search
Sponsor


See Latest Articles


